Upcoming National Audit – Analysis of Prescription Drug Event Records for Adcirca, Revatio, and Cialis (ARC) Drugs Prescribed without a Documented Medically Accepted Indication

Relevant to: PDPs, MA-PD

The Centers for Medicare & Medicaid Services (CMS), in collaboration with the Plan Program Integrity Medicare Drug Integrity Contractor (PPI MEDIC), is conducting a review of Medicare Part D Payments for ARC drugs prescribed without a documented medically accepted indication (MAI) under the Medicare Part A, Part B, or Part C programs.

See the full guidance for more information.